Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. Stephen MacMillan

Market Cap

18.21 Billion EUR

Sector

Healthcare

Website

https://www.hologic.com/

Description

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women.

Read More

Overview

Value

67

Growth

72

Health

71

Management

63

Analyst Opinion

86

Total

72

All Scores Out Of 100

Best Features

  • Very strong cashflow and earnings growth
  • Has a low level of debt
  • Has a history of share buybacks
  • Low risk of bankruptcy
  • Has strong financial health
  • Price-to-earnings ratio of 13.7 is lower than the market average (19.6x)
  • Liked by analysts
  • Low preportion of income is paid as dividend
  • 0

Risk Factors

  • Earnings have declined recently

Market Peers

HO1.DE

Key Figures

PE Ratio (TTM)

13.74

Margin Of Safety (DCF)

N/A

Revenue Growth (5 Year Average)

14.43%

Ratings Consensus

Strong Buy

Share Buybacks

1.14%

Dividend Yeild (TTM)

N/A

Valuation

Value Score

67

  • Price-to-earnings ratio of 13.7 is lower than the market average (19.6x)
  • Estimated intrinsic-value of N/A is lower than current price ( 65.31 EUR)
  • Free-cashflow-yeild of N/A is worse than the market average (4.7%)
  • Margin-of-safety of N/A is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: N/ANaNNaN

Current Price: 65.3 EUR

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

13.74x

Free Cashflow Yeild

N/A

PE/Earnings Growth

N/A

Price/Book

Infinityx

Growth

Growth Score

72

  • 5 Year Average Revenue growth of 14.43% is higher than the market average (10.97%)
  • 5 Year Average Earnings growth of 24.49% is higher than the market average (14.48%)
  • 5 Year Average Cashflow growth of 19.62% is higher than the market average (12.35%)
  • Revenue growth has slowed this year
  • Earnings growth has slowed this year
  • Free Cashflow growth has slowed this year

Revenue Growth

14.43%

Earnings Growth

24.49%

Cashflow Growth

19.62%

Health

Health Score

71

  • Low risk of bankruptcy
  • Assets cover liabilities
  • Normal operation does not require debt to be sustainable
  • Debt repayments do not significantly impact cashflow

Altman Z Score

4.14

Piostroski Score

6.00

Debt/Equity

0.58x

Current Assets/Liabilities

4.12x

Free Cashflow/Total Debt

0.71x

Debt/Capital

0.73x

Management

Management Score

63

  • Has repurchased shares when value is good
  • Has a history of returning value to shareholders through stock buybacks
  • Return-on-capital-employed of 25.41% is higher than the market average (10%)
  • Return-on-equity of N/A is lower than the market average (15%)

Average Buybacks/Dilution

1.14%

Recent Buybacks/Dilution

-100.00%

5 Year Price Volitility

15.86%

Return On Assets

N/A

Return On Capital Employed

25.41%

Return On Equity

N/A

Return On Free Cashflow

N/A

Return On Investments

N/A

Analysts

Analyst Opinion

86

  • Ratings consensus is Strong Buy

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

Hologic Inc

Currency

EUR

Beta

1.41088

Vol Avg

33

Ceo

Mr. Stephen MacMillan

Cik

Cusip

Exchange

XETRA

Full Time Employees

6478

Industry

Health Care Equipment & Services

Sector

Healthcare

Ipo Date

1990-03-01

Address

250 Campus Dr

City

Marlborough

State

MASSACHUSETTS

Country

US

Zip

Phone

15082632900

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies